A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD). A recent review revisited the ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...
St. Luke’s Medical Center (SLMC) has opened an inhaler clinic service specifically designed to cater to patients with ...
The first DTC ad campaign for Viatris and Theravance’s COPD nebulizer therapy Yupelri aims to show the freedom of the once-daily treatment. In a newly debuted TV ad, an older woman celebrates her ...
OMRON HEALTHCARE Co., Ltd. has announced that its cumulative sales of nebulizers have exceeded 50 million units. This achievement highlights the company's ongoing mission to improve global respiratory ...
Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "United States Nebulizer Market Report by Type, Modality, Applications, End Use, States and Company Analysis, 2025-2033" report has been added to ...
Sellbyville, DE -- (SBWIRE) -- 06/18/2019-- Pneumatic Nebulizers Market size is set to exceed USD 875 million by 2024; according to a new research report by Global Market Insights. Rising elderly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback